Thoracic ultrasound influences physiotherapist's clinical decision-making in respiratory management of critical care patients: a multicentre cohort study.


Journal

Thorax
ISSN: 1468-3296
Titre abrégé: Thorax
Pays: England
ID NLM: 0417353

Informations de publication

Date de publication:
02 2023
Historique:
received: 20 09 2021
accepted: 14 02 2022
pubmed: 25 3 2022
medline: 17 1 2023
entrez: 24 3 2022
Statut: ppublish

Résumé

The potential influence of thoracic ultrasound on clinical decision-making by physiotherapists has never been studied. The aim of this study was to assess the impact of thoracic ultrasound on clinical decision-making by physiotherapists for critical care patients. This prospective, observational multicentre study was conducted between May 2017 and November 2020 in four intensive care units in France and Australia. All hypoxemic patients consecutively admitted were enrolled. The primary outcome was the net reclassification improvement (NRI), quantifying how well the new model (physiotherapist's clinical decision-making including thoracic ultrasound) reclassifies subjects as compared with an old model (clinical assessment). Secondary outcomes were the factors associated with diagnostic concordance and physiotherapy treatment modification. A total of 151 patients were included in the analysis. The NRI for the modification of physiotherapist's clinical decisions was-40% (95% CI (-56 to -22%), p=0.02). Among the cases in which treatment was changed after ultrasound, 41% of changes were major (n=38). Using a multivariate analysis, the physiotherapist's confidence in their clinical diagnosis was associated with diagnostic concordance (adjusted OR=3.28 95% CI (1.30 to 8.71); p=0.014). Clinical diagnosis involving non-parenchymal conditions and clinical signs reflecting abolished lung ventilation were associated with diagnostic discordance (adjusted OR=0.06 95% CI (0.01 to 0.26), p<0.001; adjusted OR=0.26 95% CI (0.09 to 0.69), p=0.008; respectively). Thoracic ultrasound has a high impact on the clinical decision-making process by physiotherapists for critical care patients. NCT02881814; https://clinicaltrials.gov.

Sections du résumé

BACKGROUND
The potential influence of thoracic ultrasound on clinical decision-making by physiotherapists has never been studied. The aim of this study was to assess the impact of thoracic ultrasound on clinical decision-making by physiotherapists for critical care patients.
METHODS
This prospective, observational multicentre study was conducted between May 2017 and November 2020 in four intensive care units in France and Australia. All hypoxemic patients consecutively admitted were enrolled. The primary outcome was the net reclassification improvement (NRI), quantifying how well the new model (physiotherapist's clinical decision-making including thoracic ultrasound) reclassifies subjects as compared with an old model (clinical assessment). Secondary outcomes were the factors associated with diagnostic concordance and physiotherapy treatment modification.
RESULTS
A total of 151 patients were included in the analysis. The NRI for the modification of physiotherapist's clinical decisions was-40% (95% CI (-56 to -22%), p=0.02). Among the cases in which treatment was changed after ultrasound, 41% of changes were major (n=38). Using a multivariate analysis, the physiotherapist's confidence in their clinical diagnosis was associated with diagnostic concordance (adjusted OR=3.28 95% CI (1.30 to 8.71); p=0.014). Clinical diagnosis involving non-parenchymal conditions and clinical signs reflecting abolished lung ventilation were associated with diagnostic discordance (adjusted OR=0.06 95% CI (0.01 to 0.26), p<0.001; adjusted OR=0.26 95% CI (0.09 to 0.69), p=0.008; respectively).
CONCLUSION
Thoracic ultrasound has a high impact on the clinical decision-making process by physiotherapists for critical care patients.
TRIAL REGISTRATION NUMBER
NCT02881814; https://clinicaltrials.gov.

Identifiants

pubmed: 35321941
pii: thoraxjnl-2021-218217
doi: 10.1136/thoraxjnl-2021-218217
doi:

Banques de données

ClinicalTrials.gov
['NCT02881814']

Types de publication

Observational Study Multicenter Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

169-175

Informations de copyright

© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Aymeric Le Neindre (A)

Respiratory Intensive Care and Clinical Research Units, Hopital Forcilles, Ferolles-Attilly, France.
UMR1231 - Lipide Nutrition Cancer, Université de Bourgogne, Dijon, France.

Louise Hansell (L)

Physiotherapy, Royal North Shore Hospital, St Leonards, New South Wales, Australia.
Sydney School of Health Sciences, The University of Sydney Faculty of Medicine and Health, Sydney, New South Wales, Australia.

Johan Wormser (J)

Intensive Care Unit, Fondation Hopital Saint Joseph, Paris, France.

Andreia Gomes Lopes (A)

Physiotherapy and Clinical Research Units, Hopital Forcilles, Ferolles-Attilly, France.

Carlos Diaz Lopez (C)

Physiotherapy, Hopital Forcilles, Ferolles-Attilly, France.

Christophe Romanet (C)

Intensive Care Unit, Fondation Hopital Saint Joseph, Paris, France.

Gerald Choukroun (G)

Soins intensifs respiratoires & Réadaptation post-réanimation, Hopital Forcilles, Ferolles-Attilly, Île-de-France, France.

Maxime Nguyen (M)

Anesthesiology and Intensive Care Medicine, University Hospital Centre of Dijon, Dijon, France.

François Philippart (F)

Intensive Care Unit, Fondation Hopital Saint Joseph, Paris, France.

Pierre-Grégoire Guinot (PG)

Anesthesiology and Intensive Care Medicine, University Hospital Centre of Dijon, Dijon, France.

Hergen Buscher (H)

Intensive Care Unit, St Vincent's Hospital Sydney, Darlinghurst, New South Wales, Australia.
South Western Sydney Clinical School, University of New South Wales, Liverpool, New South Wales, Australia.

Bélaid Bouhemad (B)

UMR1231 - Lipide Nutrition Cancer, Université de Bourgogne, Dijon, France belaid_bouhemad@hotmail.com.
Anesthesiology and Intensive Care Medicine, University Hospital Centre of Dijon, Dijon, France.

George Ntoumenopoulos (G)

Physiotherapy, St Vincent's Hospital Sydney, Darlinghurst, New South Wales, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH